Tsuyoshi Takada

Nasushiobara, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Unique left pulmonary vein isolation in straight common trunk based on longitudinal conduction of left lateral ridge.

Unique left pulmonary vein isolation in straight common trunk based on longitudinal conduction of left lateral ridge.

Journal: Pacing and clinical electrophysiology : PACE

Published: November 12, 2021

Oncostatin M is a novel biomarker for coronary artery disease - A possibility as a screening tool of silent myocardial ischemia for diabetes mellitus.

Oncostatin M is a novel biomarker for coronary artery disease - A possibility as a screening tool of silent myocardial ischemia for diabetes mellitus.

Journal: International journal of cardiology. Heart & vasculature

Published: May 27, 2021

A case of ventricular fibrillation without left ventricular systolic dysfunction induced by trastuzumab emtansine for breast cancer.

A case of ventricular fibrillation without left ventricular systolic dysfunction induced by trastuzumab emtansine for breast cancer.

Journal: Journal of cardiology cases

Published: May 13, 2021

Risk of de-novo heart failure and competing risk in asymptomatic patients with structural heart diseases.

Risk of de-novo heart failure and competing risk in asymptomatic patients with structural heart diseases.

Journal: International journal of cardiology

Published: September 15, 2019

Influence of Left Ventricular Ejection Fraction on the Effects of Supplemental Use of Angiotensin Receptor Blocker Olmesartan in Hypertensive Patients With Heart Failure.

Influence of Left Ventricular Ejection Fraction on the Effects of Supplemental Use of Angiotensin Receptor Blocker Olmesartan in Hypertensive Patients With Heart Failure.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: September 16, 2016

Prognostic Impact of Anemia in Patients With Chronic Heart Failure- With Special Reference to Clinical Background: Report From the CHART-2 Study.

Prognostic Impact of Anemia in Patients With Chronic Heart Failure- With Special Reference to Clinical Background: Report From the CHART-2 Study.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: June 09, 2015

Prognostic Impact of Diabetes Mellitus in Chronic Heart Failure According to Presence of Ischemic Heart Disease – With Special Reference to Nephropathy.

Prognostic Impact of Diabetes Mellitus in Chronic Heart Failure According to Presence of Ischemic Heart Disease – With Special Reference to Nephropathy.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: May 26, 2015

Prognostic impact of statin use in patients with heart failure and preserved ejection fraction.

Prognostic impact of statin use in patients with heart failure and preserved ejection fraction.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 10, 2015

Prognostic impact of subclinical microalbuminuria in patients with chronic heart failure.

Prognostic impact of subclinical microalbuminuria in patients with chronic heart failure.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: November 26, 2014

Prognostic Impact of Subclinical Microalbuminuria in Patients With Chronic Heart Failure.

Prognostic Impact of Subclinical Microalbuminuria in Patients With Chronic Heart Failure.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: October 31, 2014

Prevalence, predictors and prognosis of patients with heart failure requiring nursing care.

Prevalence, predictors and prognosis of patients with heart failure requiring nursing care.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: July 25, 2014

Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial.

Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial.

Journal: European heart journal

Published: July 14, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026